Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Michelle R Kuhne

2PUBLICATIONS
16CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Avionics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

Sort by Publication Date:
|Aug 22, 2024
Pharmacokinetics, pharmacodynamics, and safety of GS-3583, a FLT3 agonist Fc fusion protein, from single-ascending-dose phase I study in healthy participants.

Anees M Dauki, Nishanthan Rajakumaraswamy, Torsten Trowe

|Jan 31, 2024
Phase I Study of GS-3583, an FMS-like Tyrosine Kinase 3 Agonist Fc Fusion Protein, in Patients with Advanced Solid Tumors.

Anthony W Tolcher, Joshua D Brody, Nishanthan Rajakumaraswamy

Pageof 1

Frequent Collaborators

2 joint publications

Nishanthan Rajakumaraswamy

2 joint publications

Torsten Trowe

2 joint publications

Anees M Dauki

1 joint publications

Anthony W Tolcher

1 joint publications

Joshua D Brody

1 joint publications

Shantheri Pai

1 joint publications

Ling Han

1 joint publications

Kai-Wen Lin

1 joint publications

Michael Petrarca

1 joint publications

Shivaani Kummar

Frequent Collaborators

2 joint publications

Nishanthan Rajakumaraswamy

2 joint publications

Torsten Trowe

2 joint publications

Anees M Dauki

1 joint publications

Anthony W Tolcher

Top Related Videos

Preclinical Drug Testing in Scalable 3D Engineered Muscle Tissues
08:07

Preclinical Drug Testing in Scalable 3D Engineered Muscle Tissues

Published on : Apr 07, 2023

3.3K
A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity
11:13

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity

Published on : Jul 12, 2018

8.6K
See more related videos

Top Related Videos

Preclinical Drug Testing in Scalable 3D Engineered Muscle Tissues
08:07

Preclinical Drug Testing in Scalable 3D Engineered Muscle Tissues

Published on : Apr 07, 2023

3.3K
A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity
11:13

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity

Published on : Jul 12, 2018

8.6K
See more related videos